DK0730465T3 - Anvendelse af angiotensin III og analoger dertil til vævsreparation - Google Patents

Anvendelse af angiotensin III og analoger dertil til vævsreparation

Info

Publication number
DK0730465T3
DK0730465T3 DK94928150T DK94928150T DK0730465T3 DK 0730465 T3 DK0730465 T3 DK 0730465T3 DK 94928150 T DK94928150 T DK 94928150T DK 94928150 T DK94928150 T DK 94928150T DK 0730465 T3 DK0730465 T3 DK 0730465T3
Authority
DK
Denmark
Prior art keywords
analogues
angiotensin iii
tissue repair
wound healing
analogs
Prior art date
Application number
DK94928150T
Other languages
English (en)
Inventor
Gere Stodder Dizerega
Kathleen Elizabeth Rodgers
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of DK0730465T3 publication Critical patent/DK0730465T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94928150T 1993-09-24 1994-09-19 Anvendelse af angiotensin III og analoger dertil til vævsreparation DK0730465T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12636893A 1993-09-24 1993-09-24
PCT/US1994/010503 WO1995008337A1 (en) 1993-09-24 1994-09-19 Use of angiotensin iii and analogs thereof in tissue repair

Publications (1)

Publication Number Publication Date
DK0730465T3 true DK0730465T3 (da) 2002-04-08

Family

ID=22424455

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94928150T DK0730465T3 (da) 1993-09-24 1994-09-19 Anvendelse af angiotensin III og analoger dertil til vævsreparation

Country Status (13)

Country Link
US (1) US5629292A (da)
EP (1) EP0730465B1 (da)
JP (1) JPH09502977A (da)
AT (1) ATE210677T1 (da)
AU (1) AU706333B2 (da)
CA (1) CA2172493C (da)
DE (1) DE69429450T2 (da)
DK (1) DK0730465T3 (da)
ES (1) ES2168312T3 (da)
PT (1) PT730465E (da)
TW (1) TW311088B (da)
WO (1) WO1995008337A1 (da)
ZA (1) ZA947338B (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955430A (en) 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) * 1994-11-14 2003-03-20 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en) 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
MY121607A (en) * 1995-07-10 2006-02-28 Hyundai Curitel Inc Grid moving method of object image and apparatus using the same and compaction/motion estimation method using the same and apparatus thereof
US6110895A (en) * 1996-12-16 2000-08-29 University Of Southern California Method of promoting healing in skin grafts
US6335195B1 (en) 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
EP1410801B1 (en) 1997-01-28 2013-04-10 University Of Southern California Method for promoting hematopoietic cell proliferation and differentiation
WO1998033813A2 (en) * 1997-02-04 1998-08-06 University Of Southern California Method for accelerating healing of thermal injuries
US6197751B1 (en) 1997-11-10 2001-03-06 The United States Of America As Represented By The Department Of Health And Human Services Thymosin α1 promotes tissue repair, angiogenesis and cell migration
EP1047441A1 (en) * 1997-11-26 2000-11-02 University Of Southern California Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
US6248587B1 (en) 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
AU755225B2 (en) * 1997-12-12 2002-12-05 University Of Southern California Wound healing compositions
WO1999040106A2 (en) * 1998-02-09 1999-08-12 University Of Southern California Use of angiotensin analogues for promoting erythropoiesis
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
AU3077299A (en) 1998-03-11 1999-09-27 University Of Southern California Method of promoting production of living tissue equivalents
CA2324988A1 (en) * 1998-04-09 1999-10-21 University Of Southern California Methods for treatment and prevention of infections
US6762167B1 (en) 1998-05-11 2004-07-13 University Of Southern California Methods for treating a patient undergoing chemotherapy
EP1073453B1 (en) 1998-05-11 2005-04-13 University Of Southern California Use of angiotensin analogs for the manufacture of a medicament for increasing white blood cell survival and mobilizing haematopoietic progenitor cells following chemotherapy
US6916783B2 (en) * 1998-07-13 2005-07-12 University Of Southern California Methods for accelerating bone and cartilage growth and repair
EP1094829B8 (en) 1998-07-13 2004-09-22 University Of Southern California Methods for accelerating bone and cartilage growth and repair
EP1105149A1 (en) * 1998-08-13 2001-06-13 University Of Southern California Methods to increase blood flow to ischemic tissue
ATE286511T1 (de) * 1999-02-17 2005-01-15 Pfizer Prod Inc Fusionsproteine mit trägern welche eine doppelte immunantwort induzieren
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US7338938B2 (en) 1999-05-10 2008-03-04 University Of Southern California Methods for treating a patient undergoing chemotherapy
US6821953B1 (en) * 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
US20020082222A1 (en) * 2000-11-30 2002-06-27 Shapira Nathan Andrew Treatments for neurogenetic disorders, impulse control disorder, and wound healing
WO2002087504A2 (en) * 2001-05-01 2002-11-07 University Of Southern California Methods for inhibiting tumor cell proliferation
EP2187915B1 (en) * 2007-09-11 2011-08-31 Mondobiotech Laboratories AG Use of the peptide phpfhlfvy (renin inhibitor) in anti-angiogenic therapy of certain diseases
WO2009033820A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
CA2699069A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
RU2010113965A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Гамма-1-msh отдельно или в сочетании с пентагастрином в качестве терапевтического средства
WO2009040049A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents
WO2009114461A2 (en) * 2008-03-10 2009-09-17 University Of Southern California Angiotensin (1-7) dosage forms and uses thereof
JP5647146B2 (ja) 2008-12-29 2014-12-24 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． β−アレスチンエフェクターおよび組成物およびその使用方法
EA026440B1 (ru) 2011-02-02 2017-04-28 Университи Оф Сатерн Калифорния Способ лечения диабетической язвы стопы
AU2013215269A1 (en) 2012-01-31 2014-08-21 Trevena, Inc. Beta-arrestin effectors and compositions and methods of use thereof
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
EP3016670A4 (en) 2013-07-03 2017-01-18 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for treating cognitive dysfunction
US9518086B2 (en) 2014-02-07 2016-12-13 Trevena, Inc. Crystalline and amorphous forms of a β-arrestin effector
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
EP3145524A4 (en) 2014-05-19 2018-03-14 Trevena, Inc. Synthesis of beta-arrestin effectors
US10183055B2 (en) 2014-07-21 2019-01-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
AU2015294371B2 (en) 2014-07-21 2018-02-01 The Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides and methods for using and producing the same
US10960045B2 (en) * 2015-10-14 2021-03-30 Constant Therapeutics Llc Methods and compositions for the treatment of epidermolysis bullosa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886134A (en) * 1970-03-09 1975-05-27 Morton Norwich Products Inc Analogues of angiotensin II
US5015629A (en) * 1989-06-26 1991-05-14 University Of Southern California Tissue repair

Also Published As

Publication number Publication date
ZA947338B (en) 1995-05-10
PT730465E (pt) 2002-06-28
WO1995008337A1 (en) 1995-03-30
US5629292A (en) 1997-05-13
EP0730465A1 (en) 1996-09-11
DE69429450D1 (de) 2002-01-24
CA2172493A1 (en) 1995-03-30
CA2172493C (en) 2003-09-16
ATE210677T1 (de) 2001-12-15
ES2168312T3 (es) 2002-06-16
EP0730465A4 (en) 1997-11-12
TW311088B (da) 1997-07-21
AU7730294A (en) 1995-04-10
EP0730465B1 (en) 2001-12-12
JPH09502977A (ja) 1997-03-25
DE69429450T2 (de) 2002-07-25
AU706333B2 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
DK0730465T3 (da) Anvendelse af angiotensin III og analoger dertil til vævsreparation
MX9703609A (es) Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
DE69435301D1 (de) Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
ATE268782T1 (de) Zusammensetzungen zur wundheilung
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
DK0785948T3 (da) Analoger af keratinocyt vækstfaktor
NO991302D0 (no) Munnvask-sammensetninger
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DK0759687T3 (da) Anvendelse af gelpræparater som bejdsemidler
NO983530D0 (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
BR0111678A (pt) Composições medicinais contendo derivados de propenona
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
UY26514A1 (es) " composición para el tratamiento de tejidos danados".
ES2121109T3 (es) Composicion de champu.
MX9709983A (es) El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
AR006856A1 (es) Mezclas fungicidas sinergicas, utiles para combatir hongos fitopatogenos y su procedimiento de aplicacion
UA31714A (uk) Засіб для зовнішнього лікування гнійних ран і трофічних виразок
DE69927815D1 (de) Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden
DE50006094D1 (de) Neue flüssigformulierungen
ES2165366T3 (es) Procedimientos y composiciones para inhibir la inflamacion mediada por celulas endoteliales y fibrinogeno.
AR006268A1 (es) Metodo para inhibir la polimerizacion de isopreno y composicion obtenida mediante el mismo